NeuroPace Inc — Director's Dealing 2022

Oct 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2022-10-07

Reporting Person: Morrell Martha (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-07	Common Stock	M	192	$0.026	Acquired	56780	Direct
2022-10-07	Common Stock	M	384	$0.026	Acquired	57164	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-07	Stock Option (Right to Buy)	$0.026	M	192	Disposed	2022-11-13	Common Stock (192)	Direct
2022-10-07	Stock Option (Right to Buy)	$0.026	M	384	Disposed	2023-03-08	Common Stock (384)	Direct

Footnotes

F1: The shares underlying the option are fully vested.